Baudax Bio, Inc. (BXRXQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 25, 2024, 8:30 AM EST
Baudax Bio Revenue
Baudax Bio had revenue of $1.27M in the twelve months ending September 30, 2023, up 217.25% year-over-year. In the year 2022, Baudax Bio had annual revenue of $1.27M with 17.50% growth.
Revenue
1.27M
Revenue Growth
+217.25%
P/S Ratio
n/a
Revenue / Employee
141.00K
Employees
9
Market Cap
52.00
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Elekta AB (publ) | 1.66B |
| Ryman Healthcare Limited | 458.44M |
| Verano Holdings Corp. | 897.57M |
| Vireo Growth Inc. | 98.53M |
| Medexus Pharmaceuticals Inc. | 104.76M |